Navigation Links
Lupus Foundation of America Seeks Funding Proposals for Research Studies on Childhood Lupus, Nervous System Involvement, and More
Date:4/17/2008

WASHINGTON, April 17 /PRNewswire-USNewswire/ -- The Lupus Foundation of America (LFA) is seeking proposals for up to $1.5 million in grant funding for basic, clinical, or translational research studies on lupus, an unpredictable and potentially fatal autoimmune disease. The purposes of the studies are to: accelerate ongoing research; directly sponsor novel approaches; and develop experimental prototypes. Grants will support four areas of study: childhood, or pediatric, lupus; neuropsychiatric lupus; adult stem cells; and novel pilot projects.

As part of this request for proposals, the LFA announces its new Michael Jon Barlin Pediatric Lupus Program. There is a special urgency associated with research on pediatric lupus. Early and aggressive treatment can have a dramatic, positive impact on disease activity and on the later progression of disease. Therefore, new diagnostic and prognostic tests, as well as treatments specifically for children, are more important than ever in addressing this potentially devastating form of lupus.

Also new this year is grant funding for neuropsychiatric lupus that affects the central nervous system and the brain. These dangerous symptoms occur in 50-91 percent of those with lupus, and can be a major source of illness, severely diminished quality of life, and death. Of special importance are tools to measure disease activity and damage, and a better understanding of risk factors, disease course, and effective treatment of specific neuropsychiatric symptoms.

Binding letters of intent must be submitted by April 21, 2008. Online applications must be submitted by May 19, 2008. Awards will be announced on July 11, 2008. For additional information, visit the research section of the LFA Website at lupus.org.

The LFA is the nation's foremost nonprofit voluntary health organization dedicated to finding the causes of and cure for lupus, and providing support, services, and hope to all people affected by l
'/>"/>

SOURCE Lupus Foundation of America
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Preclinical study suggests organ-transplant drug may aid in lupus fight
2. Genes Boost Risk for Rheumatoid Arthritis, Lupus
3. The Will and Jada Smith Family Foundation and Maybelline Join Forces With the Lupus Foundation of America for a Star-studded Gala to Raise Awareness for Lupus
4. Better Lupus Treatments on the Horizon
5. Stars Shine on Butterflies Over Hollywood for Lupus Foundation of America
6. Clinical Trials for Lupus Underway After Decades of Drought
7. October is Lupus Awareness Month
8. New Round of Lupus Research Institute Awards Brings Promise of More Breakthroughs
9. Photo: New York Goes Orange for Pumpkin Festival and Lupus Awareness Month
10. Mayo Clinic shows therapy effective for reducing lupus flares
11. Research suggests targeted treatment strategies for lupus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/12/2013)... 12, 2013 Mulroy Consulting Group ... animal health manufacturers and distributors worldwide. Services include ... sales channel identification, channel contracting and management, distribution ... development, business development and identifying / developing collaborative ... Martin Mulroy, had most recently served as Chief ...
(Date:12/12/2013)... December 12, 2013 CytoGenX Corp, ... announced today it will be offering Assure™, its ... the detection and identification of disease-causing genetic alterations ... well as cancer and infertility. "Assure™, is an ... the human genome and will serve to advance ...
(Date:12/12/2013)... Nuun, the top-selling electrolyte sports drink ... is thrilled to welcome Kevin Rutherford as CEO. ... and product development efforts to further establish the ... consumer product offering and experience. , Rutherford joins ... accelerated growth both as CEO and a Marketing ...
(Date:12/12/2013)... 2013 A year-long NIOSH ... seat of our sedentary lives; namely, our workstations, where ... in front of a computer. , The findings from ... supplement recent studies highlighting health problems caused or exacerbated ... most corporate wellness programs, which tend to focus on ...
(Date:12/12/2013)... (PRWEB) December 12, 2013 ... is encouraged by additional details that have been ... allegations over recalled metal hip systems produced by ... 21, 2013 that plaintiffs who have sued over ... “if they had an ASR implanted in the ...
Breaking Medicine News(10 mins):Health News:CytoGenX Corp. Announces the Release of Assure™ Whole-Genome Microarray 2Health News:Nuun Welcomes Kevin Rutherford as CEO 2Health News:Nuun Welcomes Kevin Rutherford as CEO 3Health News:Taking a Stand for Workplace Wellness 2Health News:DePuy Metal Hip Implant Lawyer Help: Resource4thePeople Encouraged by Additional Details of Proposed $4 Billion Settlement 2Health News:DePuy Metal Hip Implant Lawyer Help: Resource4thePeople Encouraged by Additional Details of Proposed $4 Billion Settlement 3Health News:DePuy Metal Hip Implant Lawyer Help: Resource4thePeople Encouraged by Additional Details of Proposed $4 Billion Settlement 4Health News:DePuy Metal Hip Implant Lawyer Help: Resource4thePeople Encouraged by Additional Details of Proposed $4 Billion Settlement 5
... proportions, with the number of global users outnumbering other ... cocaine//. Health authorities from the U.S have warned that ... trend, it could lead to a global threat. ... known, is a stimulant that induces euphoria in its ...
... had been bitten by a bat and subsequently diagnosed with rabies ... Although treatment is being offered, the chances of the boy recovering ... a student of Humble High School fell ill last week, unaware ... before this could happen, a bat had flown into his house ...
... the University of Illinois at Chicago, it was found that ... drugged// and in 5% of the cases, the victims were ... in the United States each year, and the FBI says ... were reported, said Adam Negrusz, associate professor of forensic sciences ...
... a team at Queeen's has suggested that patients who ... to dialysis// yield better results in clearing toxins and ... exercise intervention study of dialysis patients was recently carried ... the Cardiac, Circulation and Respiratory (CCR) group at Queen's, ...
... at Johns Hopkins, Yale and other institutions have conducted a ... contributor to the severe anemia// that result from malaria, often ... in response to inflammation called MIF, which appears to suppress ... already are infected by malaria parasites. ,The parasite ...
... Recent research has revealed that more than 80 million American adults ... risk of poor health and an early death. // ... to estimate the proportion of adults in the United States who ... who fall into both categories is about 9 million people and ...
Cached Medicine News:Health News:Meth Addiction On The Rise, US Health Authorities Concerned 2Health News:UIC Study Throws Light On Sexual Assaults 2Health News:Exercise Combined with Dialysis Yields Better Results 2Health News:Anemia from Malaria Linked to a Protein MIF 2Health News:Anemia from Malaria Linked to a Protein MIF 3
(Date:12/11/2013)... Dec. 11, 2013 Imagenetix, Inc. (OTC Bulletin ... Board of Appeals for the United States Patent & ... patent no. 5,569,676 and issued a decision confirming the ... requested that its case against NIKKEN be reinstated. In ... 2011, Imagenetix seeks damages for NIKKEN,s willful infringement of ...
(Date:12/11/2013)... , Dec. 11, 2013   New England ... has expanded their offerings with the addition ... professionals at NELO perform a variety of non-invasive aesthetic ... solution to unwanted hair. Hair removal is ... and is popular amongst patients across many demographics. According ...
(Date:12/11/2013)... , Dec. 11, 2013   Zacks Equity Research ... Bull of the Day and Caterpillar (NYSE: CAT - Free ... Equity Research provides analysis on the Bristol-Myers Squibb Company (NYSE: ... Report ) and AstraZeneca (NYSE: AZN - Free Report ). ... a synopsis of all five stocks: Bull ...
Breaking Medicine Technology:Imagenetix: NIKKEN's Attempt To Invalidate Patent Fails 2New England Laser Options Adds On Professional Hair Removal with the Astanza Liberty IPL System 2Conn's, Caterpillar, Bristol-Myers Squibb, Novartis and AstraZeneca highlighted as Zacks Bull and Bear of the Day 2Conn's, Caterpillar, Bristol-Myers Squibb, Novartis and AstraZeneca highlighted as Zacks Bull and Bear of the Day 3Conn's, Caterpillar, Bristol-Myers Squibb, Novartis and AstraZeneca highlighted as Zacks Bull and Bear of the Day 4Conn's, Caterpillar, Bristol-Myers Squibb, Novartis and AstraZeneca highlighted as Zacks Bull and Bear of the Day 5Conn's, Caterpillar, Bristol-Myers Squibb, Novartis and AstraZeneca highlighted as Zacks Bull and Bear of the Day 6Conn's, Caterpillar, Bristol-Myers Squibb, Novartis and AstraZeneca highlighted as Zacks Bull and Bear of the Day 7
... 1 results demonstrating clinical activity of perifosine ... with bortezomib, and provides an update on an ongoing ... in combination with dexamethasone, NEW YORK, Dec. 10 ... that positive phase 1 & phase 2 data of,perifosine ...
... VeraTag(TM) Assays in Breast ... Cancer, SOUTH ... announced five posters to be,presented at the 30th San Antonio Breast Cancer Symposium ... details for,each embargoed session:, -- Friday, December 14th, 2007, 7.00 am ...
Cached Medicine Technology:Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology 7Monogram Announces Posters to be Presented at the 30th San Antonio Breast Cancer Symposium 2Monogram Announces Posters to be Presented at the 30th San Antonio Breast Cancer Symposium 3
For use with Snap-In Snap-Out-II tip inserts. Available in five styles, the Snap-In Snap-Out-II Laparoscopic Instrument Handles offer the broadest range available....
Inquire...
Inquire...
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
Medicine Products: